ADX vs DBRG

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a low P/E of 7.72 and a current price ($23.69) below the Graham Number ($40.16), the company exhibits alarming earnings deterioration, negative earnings growth, and a dangerously high payout ratio of 109.18%, raising sustainability concerns. Profitability margins are anomalously high—particularly the 981.24% profit margin and 100% gross margin—likely reflecting non-operational or one-time gains rather than sustainable business performance. The technical trend score of 10/100 signals strong bearish momentum, and lack of analyst coverage further limits confidence in forward visibility.

DBRG exhibits a significant disconnect between its market price ($15.60) and its fundamental value, with a Piotroski F-Score of 4/9 indicating only stable health and a Graham Number of $8.81. While the stock has seen strong 1-year price momentum (+86.3%), this is not supported by the underlying financials, which show negative revenue growth (-27.6%) and negative ROE/ROA. The valuation is extreme, evidenced by a Price/Sales ratio of 30.31 and a PEG ratio of 3.06, suggesting the stock is trading at a speculative premium far above its intrinsic value of $3.36.